IMPORTANT SAFETY INFORMATION: WARNING: RISK OF ANAPHYLAXIS, HYPERSENSITIVITY AND IMMUNE-MEDIATED REACTIONS, AND RISK OF CARDIORESPIRATORY FAILURE If you or your child is taking Lumizyme, you should know that severe and potentially life-threatening allergic-type reactions known as anaphylaxis, severe hypersensitivity reactions, and reactions related to the immune system may occur during and after Lumizyme treatment. These reactions may include extreme difficulty breathing, shallow breathing, abnormal heart rate, low blood pressure, throat tightness, face and tongue swelling, kidney dysfunction, and severe skin lesions. You should seek immediate medical care if signs and symptoms of anaphylaxis, hypersensitivity reactions, and immune system reactions occur. View more

Access Denied

You are about to leave Lumizyme.com.

Sanofi Genzyme does not review or control the content of non-Sanofi Genzyme websites, and this hyperlink does not constitute an endorsement by Sanofi Genzyme of a non-Sanofi Genzyme site's content. Sanofi Genzyme’s privacy procedures do not apply to the owners of a non-Sanofi Genzyme website.